Imugene Limited carries a market capitalization of 36.18M, placing it among publicly traded companies globally.
| Market Cap | 36.18M |
| Enterprise Value | N/A |
Imugene Limited's stock has declined approximately -74.55882% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | -74.55882% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.18 |
| Average Volume (20 Days) | N/A |
Imugene Limited's most recent stock split took place on July 2, 2025 with a 34:1 split ratio.
| Last Split Date | 7/2/2025 |
| Split Ratio | 34:1 |